Data processing: measuring – calibrating – or testing – Measurement system in a specific environment – Biological or biochemical
Reexamination Certificate
2005-02-22
2005-02-22
Marschel, Ardin H. (Department: 1631)
Data processing: measuring, calibrating, or testing
Measurement system in a specific environment
Biological or biochemical
C435S006120, C435S007100, C435S069100, C703S011000
Reexamination Certificate
active
06859735
ABSTRACT:
The present invention provides methods and computer systems for identifying and representing the biological pathways of drug action on a cell The present invention also provides methods and computer systems for assessing the significance of the identified representation and for verifying that the identified pathways are actual pathway of drug action. The present invention also provides methods and computer systems for drug development based on the methods for identifying biological pathways of drug action, and methods and computer systems for representing the biological pathways involved in the effect of an environmental change upon a cell.
REFERENCES:
patent: 5331573 (1994-07-01), Balaji et al.
patent: 5434796 (1995-07-01), Weininger
patent: 5445934 (1995-08-01), Fodor et al.
patent: 5569588 (1996-10-01), Ashby et al.
patent: 5645988 (1997-07-01), Vande Woude et al.
patent: 5657255 (1997-08-01), Fink et al.
patent: 5744305 (1998-04-01), Fodor et al.
patent: 5777888 (1998-07-01), Rine et al.
patent: 5800992 (1998-09-01), Fodor et al.
patent: 5811231 (1998-09-01), Farr et al.
patent: 5930154 (1999-07-01), Thalhammer-Reyero
patent: 6132969 (2000-10-01), Stoughton et al.
patent: 6165709 (2000-12-01), Friend et al.
patent: 20020091666 (2002-07-01), Rice et al.
patent: 20030033127 (2003-02-01), Lett
patent: 20030154003 (2003-08-01), Eker et al.
patent: 0 816 511 (1996-01-01), None
patent: WO 9417208 (1994-08-01), None
patent: WO 9710365 (1997-03-01), None
patent: WO 9727317 (1997-07-01), None
patent: WO 9806874 (1998-02-01), None
Straus and Weiss, 1992, “Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor”, Cell 70:585-593.
Thomas et al., 1995, “Dynamical behaviour of biological regulatory networks—I. Biological role of feedback loops and practical use of the concept of the loop-characteristic state”, Bull. Math. Biol. 57:247-276.
Yuh et al., 1998, “Genomic Cis-regulatory logic: experimental and computational analysis of a sea urchin gene”, Science 279:1896-1902.
Velculescu et al., 1995, “Serial analysis of gene expression”, Science 270:484-487.
Zhao et al., 1995, “High-density cDNA filter analysis: a novel approach for large-scale, quantitative analysis of gene expression”, Gene 156:207-213.
Ecker et al., 1997 “Estimation of the chemosensitizing activity of modulators of multi-drug resistance via combined simultaneous analysis of sigmoidal dose response curve”, J. Pharm. Pharmacol. 49:305-309.
Uhlmann et al., 1990, “Antisense oligonucelotides: A new therapeutic principle”, Chemical Rev. 90(4):543-584.
Anderson et al., 1994, “Involvement of the protein tyrosine kinase p56lckin T cell signalling and thymocyte development”, Adv. Immunol. 56:151-178.
U.S. Appl. No. 09/031,216, filed Feb. 26, 1998, Friend et al.
U.S. Appl. No. 09/099,722, filed Jun. 19, 1998, Stoughton et al.
U.S. Provisional Appl. No. 60/084,742, filed May 8, 1998, Friend et al.
U.S. Provisional Appl. No. 60/090,004, filed Jun. 19, 1998, Friend et al.
U.S. Provisional Appl. No. 60/090,046, filed Jun. 19, 1998, Friend et al.
U.S. Provisional Appl. No. 60/092,512, filed Jul. 13, 1998, Friend et al.
Baudin et al., 1993, “A simple and efficient method for direct gene deletion in Saccharomyces cerevisiae”, Nucl. Acids Res. 21:3329-3330.
Belshaw et al., 1996, “Controlling protein association and subcellular localization with a synthetic ligand that induces heterodimerization of proteins”, Proc. Natl. Acad. Sci. USA 93:4604-4607.
Biocca, 1995, “Intracellular immunization: antibody targeting to subcellular compartments”, Trends in Cell Biology 5:248-253.
Blanchard et al., 1996, “Sequence to array: probing the genome's secrets”, Nature Biotechnology 14:1649.
Blanchard et al., 1996, “High-density oligonucleotide arrays”, Biosensors & Bioelectronics 11:687-690.
Chee et al., 1996, “Accessing genetic information with high-density DNA arrays”, Science 274:610-614.
Cotten and Birnstiel, 1989, “Ribozyme mediated destruction of RNA in vivo”, EMBO J. 8:3861-3866.
Dohmen et al., 1994, “Heat-inducible degron: a method for constructing temperature-sensitive mutants”, Science 263:1273-1276.
Gari et al., 1997, “A set of vectors with a tetracycline-regulatable promoter system for modulated gene expression in Saccharomyces crevisiae”, Yeast 13:837-848.
Goffreau et al., 1996, “Life with 6000 genes”, Science 274:546-567.
Gossen and Bujard, 1992, “Tight control of gene expression in mammalian cells by tetracycline-responsive promoters”, Proc. Natl. Acad. Sci. USA 89:5547-5551.
Gossen et al., 1995, “Transcriptional activation by tetracyclines in mammalian cells” Science 268:1766-1769.
Guo et al., 1994, “Direct fluorescence analysis of genetic polymorphisms by hybridization with oligonucleotide arrays on glass supports”, Nucl. Acids. Res. 22:5456-5465.
Hanke et al., 1996, “Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor”, J. Biol. Chem. 271:695-701.
Hartwell et al., 1997, “Integrating genetic approaches into the discovery of anticancer drugs”, Science 278:1064-1068.
Hayden et al., 1997, “Antibody engineering”, Curr, Opin. Immunol. 9:201-212.
Herskowitz, 1987, “Functional inactivation of genes by dominant negative mutations”, Nature 329:219-222.
Hoffmann et al., 1997, “A novel tetracycline-dependent expression vector with low basal expression and potent regulatory properties in various mammalian cell lines”, Nucl. Acids Res. 25:1078-1079.
Johnston and Davis, 1984, “Sequences that regulate the divergent GAL1-GAL10 promoter in Saccharomyces cerevisiae”, Mol. Cell. Biol. 4:1440-1448.
Kerjan et al., 1986, “Nucleotide sequence of Saccharomyces cerevisiae MET25 gene”, Nucl. Acids Res. 14:7861-7871.
Lander, 1996, “The new genomics: Global views of biology”, Science 274:536-539.
Lennon and Lehrach, 1991, “Hybridization analyses of arrayed cDNA libraries” TIG 7:314-317.
Mascorro-Gallardo et al., 1996, “Construction of a CUP1 promoter-based vector to modulate gene expression in Saccharomyces cerevisiae”, Gene 172:169-170.
Matheos et al., 1997, “Tcn1p/Crz1p, a calcineurin-dependent transcription factor that differentially regulates gene expression in Saccharomyces cerevisiae”, Genes & Dev. 11:3445-3458.
McAdams and Shapiro, 1995, “Circuit simulation of genetic networks”, Science 269:650-656.
Mikulecky, 1990, “Modeling intestinal absorption and other nutrition-related processes using PSPICE and STELLA”, J. Ped. Gastroenterol. Nutr. 11:7-20.
Mounts and Liebman, 1997, “Qualitative modeling of normal blood coagulation and its pathological states using stochastic activity networks”, Int. J. Biol. Macromolecules 20:265-281.
Mumberg et al., 1994, “Regulatable promoters of Saccharomyces cerevisiae: Comparison of transcriptional activity and their use for heterologous expression”, Nucl. Acids. Res. 22:5767-5768.
Nguyen et al., 1995, “Differential gene expression in the murine thymus assayed by quantitative hybridization of arrayed cDNA clones”, Genomics 29:207-216.
No et al., 1996, “Ecdysone-inducible gene expression in mammalian cells and transgenic mice”, Proc. Natl. Acad. Sci. USA 93:3346-3351.
Nocka et al., 1990, Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41and W11, EMBO J. 9:1805-1813.
Oliff and Friend, 1997, “Cancer, principles & practice of oncology, molecular targets for drug development”, Mol. Pharmacol. 68:3115-3125.
Perlmutter and Alberola-lla, 1996, “The use of dominant-negative mutations to elucidate signal trans
Friend Stephen H.
Stoughton Roland
Jones Day
Marschel Ardin H.
Rosetta Inpharmatics LLC
LandOfFree
Computer systems for identifying pathways of drug action does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Computer systems for identifying pathways of drug action, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Computer systems for identifying pathways of drug action will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3461365